EpCAM expression in squamous cell carcinoma of the oral cavity: Frequency and relationship to clinicopathologic features

Oral Oncology

Volumn 44, Issue 1, 2008, Pages 72-77

  Laimer, Klaus ^a   Fong, Dominic ^a   Gastl, Guenther ^a   Obrist, Peter ^a   Kloss, Frank ^a   Tuli, Tarkan ^a   Gassner, Robert ^a   Rasse, Michael ^a   Norer, Burghard ^a   Spizzo, Gilbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

EpCAM; Oral squamous cell carcinoma; Prognosis; Tissue microarray

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PARAFFIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 37049037972     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.01.008     Document Type: Article

References (39)

1. Muir C., and Weiland L. Upper aerodigestive tract cancers. Cancer 75 Suppl. 1 (1995) 147-153
2. Koppikar P., deVilliers E.M., and Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 113 6 (2005) 946-950
3. Llewellyn C.D., Linklater K., Bell J., Johnson N.W., and Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 40 3 (2004) 304-313
4. Moreno-Lopez L.A., Esparza-Gomez G.C., Gonzalez-Navarro A., Cerero-Lapiedra R., Gonzalez-Hernandez M.J., and Dominguez-Rojas V. Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain. Oral Oncol 36 2 (2000) 170-174
5. Miller C.S., Henry R.G., and Rayens M.K. Disparities in risk of and survival from oropharyngeal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 5 (2003) 570-575
6. Wolff D., Hassfeld S., and Hofele C. Influence of marginal and segmental mandibular resection on the survival rate in patients with squamous cell carcinoma of the inferior parts of the oral cavity. J Craniomaxillofac Surg 32 5 (2004) 318-323
7. Sasaki T., Moles D.R., Imai Y., and Speight P.M. Clinico-pathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age. J Oral Pathol Med 34 3 (2005) 129-133
8. Sciubba J.J. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol 2 4 (2001) 239-251
9. Andreadis C., Vahtsevanos K., Sidiras T., Thomaidis I., Antoniadis K., and Mouratidou D. 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer. Oral Oncol 39 4 (2003) 380-385
10. Litvinov S.V., Bakker H.A., Gourevitch M.M., Velders M.P., and Warnaar S.O. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun 2 5 (1994) 417-428
11. Litvinov S.V., Velders M.P., Bakker H.A., Fleuren G.J., and Warnaar S.O. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125 2 (1994) 437-446
12. Balzar M., Winter M.J., de Boer C.J., and Litvinov S.V. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77 10 (1999) 699-712
13. Spurr N.K., Durbin H., Sheer D., Parkar M., Bobrow L., and Bodmer W.F. Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI. Int J Cancer 38 5 (1986) 631-636
14. Calabrese G., Crescenzi C., Morizio E., Palka G., Guerra E., and Alberti S. Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92 1-2 (2001) 164-165
15. Poczatek R.B., Myers R.B., Manne U., Oelschlager D.K., Weiss H.L., Bostwick D.G., et al. Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol 162 4 (1999) 1462-1466
16. Litvinov S.V., van Driel W., van Rhijn C.M., Bakker H.A., van Krieken H., Fleuren G.J., et al. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148 3 (1996) 865-875
17. Spizzo G., Obrist P., Ensinger C., Theurl I., Dunser M., Ramoni A., et al. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer. Int J Cancer 98 6 (2002) 883-888
18. Spizzo G., Went P., Dirnhofer S., Obrist P., Simon R., Spichtin H., et al. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 86 3 (2004) 207-213
19. Gastl G., Spizzo G., Obrist P., Dunser M., and Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356 9246 (2000) 1981-1982
20. Varga M., Obrist P., Schneeberger S., Muhlmann G., Felgel-Farnholz C., Fong D., et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10 9 (2004) 3131-3136
21. Munz M., Kieu C., Mack B., Schmitt B., Zeidler R., and Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23 34 (2004) 5748-5758
22. Osta W.A., Chen Y., Mikhitarian K., Mitas M., Salem M., Hannun Y.A., et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64 16 (2004) 5818-5824
23. Ragnhammar P., Fagerberg J., Frodin J.E., Hjelm A.L., Lindemalm C., Magnusson I., et al. Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma-long-lasting, complete remissions can be induced. Int J Cancer 53 5 (1993) 751-758
24. Riethmuller G., Holz E., Schlimok G., Schmiegel W., Raab R., and Pichlmayr R. Monoclonal antibody therapy for resected Dukes'C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 16 5 (1998) 1788-1794
25. Spizzo G., Went P., Dirnhofer S., Obrist P., Moch H., Baeuerle P.A., et al. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol May 5 (2006)
26. Fong D., Steurer M., Obrist P., Barbieri V., Margreiter R., Amberger A., et al. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol June 14 (2006)
27. Chaubal S., Wollenberg B., Kastenbauer E., and Zeidler R. Ep-CAM - a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res 19 3B (1999) 2237-2242
28. Prang N., Preithner S., Brischwein K., Goster P., Woppel A., Muller J., et al. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer 92 2 (2005) 342-349
29. Schlereth B., Fichtner I., Lorenczewski G., Kleindienst P., Brischwein K., da Silva A., et al. Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct. Cancer Res 65 7 (2005) 2882-2889
30. de Bono J.S., Tolcher A.W., Forero A., Vanhove G.F., Takimoto C., Bauer R.J., et al. ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas. Clin Cancer Res 10 22 (2004) 7555-7565
31. Seligson D.B., Pantuck A.J., Liu X., Huang Y., Horvath S., Bui M.H., et al. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10 8 (2004) 2659-2669
32. Laimer K., Spizzo G., Gastl G., Obrist P., Brunhuber T., Fong D., et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 43 2 (2007) 193-198
33. Jane C., Nerurkar A.V., Shirsat N.V., Deshpande R.B., Amrapurkar A.D., and Karjodkar F.R. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 35 10 (2006) 595-601
34. Li C., Feng H.C., Chen J.C., and Song Y.F. Expression and significance of angiopoietin-1 and angiopoietin-2 in oral squamous cell cacinoma. Ai Zheng 24 11 (2005) 1388-1393
35. Lo M.L., Campisi G., Farina A., Rubini C., Pannone G., Serpico R., et al. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. BMC Cancer 5 (2005) 63
36. Wang Q.X., Shen L., and Sun C.F. Investigation of extracellular signal-regulated protein kinase and lymphnode metastasis in oral squamous cell carcinoma. Shanghai Kou Qiang Yi Xue 14 1 (2005) 18-20
37. Choi S.W., Park S.Y., Hong S.P., Pai H., Choi J.Y., and Kim S.G. The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma. J Oral Pathol Med 33 9 (2004) 533-537
38. Wang Y.F., Chow K.C., Chang S.Y., Chiu J.H., Tai S.K., Li W.Y., et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 90 11 (2004) 2186-2193
39. Lo M.L., Campisi G., Farina A., Rubini C., Ferrari F., Falaschini S., et al. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumors. Anticancer Res 26 2B (2006) 1343-1349